Skip to main content
OpenTrials

Clinical trial condition

Hypersensitivity, Immediate

Explore clinical trials studying Hypersensitivity, Immediate. Study availability and eligibility vary by location and protocol.

6,751 public trials 635 recruiting studies
Refine in advanced search Browse all conditions

Hypersensitivity, Immediate trial results

Completed

A Study to Evaluate the Relationship Between Use of Albuterol Multidose Dry Powder Inhaler With an eModule (eMDPI) and Exacerbations in Participants With Asthma

NCT02969408

Conditions
Asthma, Bronchial Diseases, Hypersensitivity, +6 more
Locations
  • Teva Investigational Site 13964 Litchfield Park, Arizona, United States
  • Teva Investigational Site 13959 Bakersfield, California, United States
  • Teva Investigational Site 13954 Los Angeles, California, United States
  • Teva Investigational Site 13923 Orange, California, United States
View all 44 locations
View Trial Details
Completed

A Chronic-Dose Safety and Efficacy Study of Albuterol Multi-Dose Dry Powder Inhaler in Pediatric Asthmatics

NCT02126839

Conditions
Asthma, Bronchial Diseases, Hypersensitivity, +6 more
Locations
  • Teva Investigational Site 12496 Birmingham, Alabama, United States
  • Teva Investigational Site 12500 Mobile, Alabama, United States
  • Teva Investigational Site 12481 Little Rock, Alaska, United States
  • Teva Investigational Site 12515 Anaheim, California, United States
View all 52 locations
View Trial Details
Completed

A Safety and Efficacy Study of Beclomethasone Dipropionate Delivered Via Breath-Actuated Inhaler (BAI) or Metered-Dose Inhaler (MDI) in Participants Ages 4-11 Years Old With Persistent Asthma

NCT02040766

Conditions
Asthma, Bronchial Diseases, Hypersensitivity, +6 more
Locations
  • Teva Investigational Site 12346 Hoover, Alabama, United States
  • Teva Investigational Site 12294 Montgomery, Alabama, United States
  • Teva Investigational Site 10925 Phoenix, Arizona, United States
  • Teva Investigational Site 12349 Little Rock, Arkansas, United States
View all 102 locations
View Trial Details
Completed

A Study of EDP1066 in Healthy Participants and Participants With Mild to Moderate Psoriasis and Atopic Dermatitis

NCT03542994

Conditions
Atopic Dermatitis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, +11 more
Locations
  • University of Surrey Clinical Research Center Guildford, Surrey, United Kingdom
  • MAC Clinical Research Barnsley, United Kingdom
  • MAC Clinical Research Cannock, United Kingdom
  • Royal Liverpool Clinical Research Unit Liverpool, United Kingdom
View Trial Details
Completed

Study of Fluticasone Propionate Multidose Dry Powder Inhaler Compared With Fluticasone Propionate/Salmeterol Multidose Dry Powder Inhaler

NCT02980133

Conditions
Asthma, Bronchial Diseases, Hypersensitivity, +6 more
Locations
  • Teva Investigational Site 13881 Birmingham, Alabama, United States
  • Teva Investigational Site 13883 Little Rock, Arkansas, United States
  • Teva Investigational Site 13906 Bakersfield, California, United States
  • Teva Investigational Site 14615 Corona, California, United States
View all 118 locations
View Trial Details
Completed

Efficacy and Safety Study of FP MDPI Compared With FS MDPI in Adolescent and Adult Patients With Persistent Asthma

NCT02141854

Conditions
Asthma, Bronchial Diseases, Hypersensitivity, +6 more
Locations
  • Teva Investigational Site 12429 Birmingham, Alabama, United States
  • Teva Investigational Site 12599 Little Rock, Alaska, United States
  • Teva Investigational Site 12609 Phoenix, Arizona, United States
  • Teva Investigational Site 12445 Costa Mesa, California, United States
View all 154 locations
View Trial Details

Related conditions